Alimera Sciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference
05 Settembre 2023 - 2:00PM
Alimera Sciences Inc. (Nasdaq: ALIM) (“Alimera”), a global
pharmaceutical company whose mission is to be invaluable to
patients, physicians and partners concerned with retinal health and
maintaining better vision longer, announced today that Rick
Eiswirth, President and Chief Executive Officer, will present a
corporate overview at the H.C. Wainwright 25th Annual Global
Investment Conference. The conference is being held on September 11
– 13, 2023 at the Lotte New York Palace Hotel.
| Presentation
Date: |
Monday,
September 11, 2023 |
| Time: |
11:30am ET |
| |
|
Mr. Eiswirth and Mr. Russell Skibsted, Chief Financial Officer,
will be available for one-on-one meetings with investors who are
registered to attend the conference. To request a meeting and to
register for the conference, please click here:
https://hcwevents.com/annualconference/
About Alimera Sciences, Inc.Alimera Sciences a
global pharmaceutical company whose mission is to be invaluable to
patients, physicians and partners concerned with retinal health and
maintaining better vision longer. For more information, please
visit: www.alimerasciences.com
|
For investor inquiries: |
For media inquiries: |
| Scott Gordon |
Jules Abraham |
| for Alimera Sciences |
for Alimera Sciences |
| scottg@coreir.com |
julesa@coreir.com |
Grafico Azioni Alimera Sciences (NASDAQ:ALIM)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Alimera Sciences (NASDAQ:ALIM)
Storico
Da Mag 2023 a Mag 2024
